The effect of Barlow's unified protocol for transdiagnostic treatment on emotional symptoms, pain catastrophizing, fear of movement and disease activity in patients with rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231210060327N1

Enrollment

Registered

2024-04-19

Start date

2024-01-23

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis. Rheumatoid arthritis, unspecified

Interventions

Intervention 1: Intervention group: unified protocol for transdiagnostic treatment for 8 sessions of 45 minutes.This treatment is generally used to help people who suffer from emotional disorders, reg

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age range from 18 to 60 years old Rheumatoid arthritis has been diagnosed by a specialist At least 6 months have passed since the diagnosis of the disease by a specialist There is no other psychological illness at the same time Informed consent to participate in the research Keeping the type and amount of drug used constant during the research period Education level of at least fifth grade

Exclusion criteria

Exclusion criteria: The presence of any chronic physical disease such as cancer and MS at the same time, except for rheumatoid arthritis Drug use Alcohol consumption Absence in more than two meetings Lack of participation and homework The appearance of suicidal thoughts or the experience of the death of a loved one Taking antidepressants and anti-anxiety drugs

Design outcomes

Primary

Measure	Time frame
Emotional symptoms (stress,anxiety,depression). Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Questionnaire DASS-21.;Pain catastrophizing. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: PCS questionnaire.;Fear of movement. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Tampa questionnaire.;Disease activity. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DAS-28 questionnaire.;Difficulty regulating emotions. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DERS questionnaire.	—

Measure

Time frame

Emotional symptoms (stress,anxiety,depression). Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Questionnaire DASS-21.;Pain catastrophizing. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: PCS questionnaire.;Fear of movement. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: Tampa questionnaire.;Disease activity. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DAS-28 questionnaire.;Difficulty regulating emotions. Timepoint: At the beginning of the study, after the end of the intervention. Method of measurement: DERS questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZhina Zarif Khalili Yazdani

Kashan University of Medical Sciences

zhina.yzn@gmail.com+98 933 944 0984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026